NCT07877532Not yet recruiting
Serratus Anterior Plane Block for Recovery After Minimally Invasive CABG
Effect of Ultrasound-Guided Serratus Anterior Plane Block on Postoperative Recovery Quality in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting: A Single-Center, Randomized, Double-Blind Controlled Trial
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
Coronary artery bypass surgery is an important treatment method for severe coronary heart disease. Among them, minimally invasive bypass surgery, although having less trauma, requires a small incision on the left chest. During the operation, the ribs need to be opened and the muscles of the chest wall pulled, which is prone to causing intercostal nerve damage. Therefore, many patients still experience severe incision pain and chest wall pain after the surgery. This study adopted the "Serratus Anterior Plane Block", which is a regional anesthesia technique. The doctor will inject the anesthetic drug into the gap near the pectoralis major muscle (a muscle located on the side of the chest) under ultrasound guidance. This technique can effectively block the nerves that transmit pain signals, thereby providing good analgesic effects for the anterior lateral chest wall and helping patients alleviate postoperative pain.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 168 (estimated)
- First submitted
- 18 Sept 2026
- Start date
- Sept 2026
- Primary completion date
- Apr 2027
- Lead sponsor
- Chinese PLA General Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT07877532
What you commit to
- Study type: Interventional
- Planned participants: 168
- From Sept 2026 to the primary completion date, Apr 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Undergoing emergency surgery;
Other illness
- Known allergy to local anesthetics (Ropivacaine);
- Coagulation disorders or infection at the puncture site;
- Cognitive impairment or inability to cooperate with pain assessment and questionnaire completion;
- Severe hepatic or renal insufficiency.
Other
- ASA physical status class IV or higher;
Who the study is looking for
- Age 18 to 80 years;
- Scheduled to undergo elective minimally invasive coronary artery bypass grafting (MIDCABG);
- Able to understand and complete the 15-item Quality of Recovery (QoR-15) questionnaire;
- Provision of written informed consent.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.